Made in CA features Pillcheck

A proudly Canadian innovative company, Pillcheck was recently featured in an exclusive interview with Made in CA. In the interview, Pillcheck CEO Veronika Litinski talks about the inspiration behind our pharmacogenetic (PGx) service, how we help individuals and their doctors use DNA-guided prescribing to achieve effective therapy faster, and our...

Pillcheck wins Arthritis Society Canada’s 2023 Award. Innovation is key to transforming arthritis care.

We're thrilled to announce that the Pillcheck team was honoured to be among the four winners, selected from top innovators across Canada, at the Arthritis Society Canada’s 2023 Arthritis Ideator Awards. Fueled by the trust and support of donors and volunteers, Arthritis Society Canada is fighting the fire of arthritis with...

Pillcheck: Optimizing Medication Plans for Seniors with Dementia

Centre for Aging + Brain Health Innovation (CABHI) study finds that Pillcheck helped identify medications that were not effective or posed a high risk of side effects for long-term care residents. The revised medication plans significantly improved the management of depression and chronic pain and reduced the risk of complications...

Independent study shows Pillcheck improves treatment for depression and anxiety

A randomized controlled trial showed that people suffering from depression and anxiety recovered faster when their medications were optimized using Pillcheck pharmacogenetics testing (also known as pharmacogenomics or PGx testing). The study evaluated the impact of pharmacogenomics-guided prescribing versus standard antidepressant treatment of depression and anxiety in three large community...

The role of pharmacogenetics for the benefits sponsor community

How COVID is forcing the accelerated evolution of health benefits services and the role of pharmacogenetics in helping plan members get the right medications to support recovery from a wide variety of pandemic-related health issues. Click the image below to read the full article or download the...

GeneYouIn and Canada Life broaden access to pharmacogenetic testing

Pillcheck preferred retail pricing now available to all Canada Life health insurance customers

January 7, 2021, Toronto, ON – GeneYouIn Inc., a leader in personalized medicine, today announced it is growing its relationship with Canada Life, a leading health insurer. The new deal will give preferred retail pricing to all of...

Pillcheck PGx launches new program for benefits advisors on the heels of positive study results in the mental health area

The new program builds on the successful introduction of Pillcheck pharmacogenetics by many insurers seeking to impact the frequency and duration of Short-Term and Long-Term disability claims. Now the same rigorously evaluated, secure service is available to plans and benefit advisors on a subscription basis or as a private purchase...

New Pillcheck Study in Long Term Care shows the potential benefit of matching people’s drug treatment to their DNA in Elder Care

Study shows that over 80% could benefit from a pharmacogenetic test and improve treatment.

Many older adults, especially those in elder care, are at risk of harmful medication-related side effects. Often, the issues are preventable with an easy pharmacogenetic test and a medication review by an expert pharmacist. A recent study involving...

DNA Test Now Personalizes Your Meds, Featured on Global News

About half of all prescription medications are ineffective. You read that right. HALF of us are taking meds that don’t work for us for a variety of reasons. People respond to medications differently. In fact, 95% of us have variations that determine how we respond to certain drugs and the subtleties of...

Do Genetic Tests Belong in Benefit Plans?

Genetic tests can provide predictive insights into many domains, such as ancestry, inherited predisposition to disease or your body’s ability to respond to a certain medication treatment – pharmacogenetics. Veronika Litinski, Pillcheck’s CEO, discusses the benefits for plans and the context for successfully implementing precision medicine with plan members.

Skip to content